Product

REKOVELLE®

Aliases

follitropin delta

Name

Gonal-f RFF Redi-ject

INN Name

FOLLITROPIN

FDA Approved

Yes

1 clinical trial

2 organizations

1 indication

2 documents

Indication

Controlled Ovarian Stimulation

Clinical trial

Nordics and Switzerland Prospective Multicentre Non-Interventional Observational Study to Assess the Pattern of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation (IVF) or Intracytoplasmic Sperm Injection (ICSI) Procedures in Routine Clinical Practice (NORSOS)

Status: Completed, Estimated PCD: 2024-03-14

Document

DailyMed Label: Gonal-f RFF Redi-ject

Organization

EMD Serono, Inc.

Document

DailyMed Label: Follistim AQ

Organization